FDA approves Vanta, a recharge-free implantable neurostimulator for chronic pain – Medtronic
Medtronic plc announced it has received FDA approval for Vanta, a high performance recharge-free implantable neurostimulator (INS) with a device life that can be optimized up to 11… read more.